Xcout IntelSign inSubscribe
Company directory

Browse companies — page 18 of 35

Every company in Xcout Intel's live graph, 100 at a time. Click through for competitors, funding, hiring signals and more. Back to the companies hub.

East West Bancorp, Inc.EWBC · Banks - DiversifiedPasadena, United States
Public

East West Bancorp, Inc. functions as the parent entity for East West Bank, which delivers a comprehensive suite of personal and commercial banking solutions to both businesses and individual clients. The organization segments its operations into three primary areas: Consumer and Business Banking, Commercial Banking, and Other activities. Customers can access various deposit accounts, including personal and business checking and savings options, money market accounts, and certificates of deposit. The bank's extensive lending portfolio covers residential mortgages and home equity loans, commercial and residential real estate financing, working capital lines of credit, construction loans, trade finance, letters of credit, general commercial business loans, affordable housing initiatives, asset-based lending, asset-backed finance, project finance, and equipment financing. A notable specialization includes financial bridging services aimed at facilitating business transactions between the United States and China. Furthermore, East West Bancorp offers ancillary services such as wealth management, treasury management, foreign exchange, and risk hedging for interest rates and commodities. Digital banking conveniences, like mobile and online platforms, are also provided. As of January 27, 2022, the company operated a significant network of approximately 120 locations spanning the United States and China. This footprint included full-service branches in international hubs like Hong Kong, Shanghai, Shantou, and Shenzhen, alongside representative offices in Beijing, Chongqing, Guangzhou, Taipei, and Xiamen. East West Bancorp, Inc. was established in 1998 and maintains its corporate headquarters in Pasadena, California.

Market cap$17.4B
Employees3,400
East West Bancorp, Inc. competitors & alternatives →
Fortress Biotech, Inc.FBIO · BiotechBay Harbor Islands, United States
Public

Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from moderate-to-severe inflammatory lesions to severe cases). Other products in this segment are Exelderm cream for fungal skin infections like ringworm and jock itch, Ceracade for dry skin conditions, Luxamend for wound care, and Accutane capsules for particularly severe, stubborn nodular acne. Its pipeline features several promising late-stage drug candidates, targeting a diverse range of medical needs. These include intravenous Tramadol for acute post-operative pain, CUTX-101 (an injection for Menkes disease), MB-107 and MB-207 for X-linked severe combined immunodeficiency, Cosibelimab for metastatic cancers, CK-101 for non-small cell lung cancer characterized by EGFR mutations, CAEL-101 for amyloid light chain (AL) amyloidosis, the Triplex vaccine for cytomegalovirus, and CEVA101 for critical traumatic brain injuries in adults and children. Furthermore, its earlier-stage research encompasses various investigational treatments such as MB-102 for blastic plasmacytoid dendritic cell neoplasm, MB-101 for glioblastoma, MB-104 for multiple myeloma and light chain amyloidosis, MB-106 for B-cell non-Hodgkin lymphoma, MB-103 for glioblastoma and metastatic breast cancer to the brain, MB-108, MB-105 for prostate and pancreatic malignancies, and BAER-101. In the preclinical phase, Fortress Biotech is exploring an array of novel therapeutic approaches. These comprise AAV-ATP7A and AVTS-001 (both gene-based therapies), the CK-103 BET inhibitor, CEVA-D and CEVA-102, CK-302 (an antibody targeting GITR), CK-303 (an antibody against CAIX), ConVax, and the ONCOlogues oligonucleotide platform. The company also actively engages in collaborative ventures with universities, research institutions, and other pharmaceutical organizations. Originally established in 2006, the entity operated as Coronado Biosciences, Inc. before rebranding as Fortress Biotech, Inc. in April 2015. Its corporate headquarters are situated in Bay Harbor Island, New York.

Market cap$68.4M
Employees101
Fortress Biotech, Inc. competitors & alternatives →
Ligand Pharmaceuticals IncorporatedLGND · PharmaceuticalsJupiter, United States
Public

Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration. The company’s comprehensive product lineup further extends to the Aziyo portfolio, featuring pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune disorders; Vivitra for breast cancer; Bryxta and Zybev for a variety of indications; and Minnebro for managing hypertension. Beyond its own commercialized products, Ligand Pharmaceuticals collaborates with partners on numerous programs currently undergoing clinical development, targeting conditions such as cancer, seizure disorders, diabetes, cardiovascular ailments, muscle wasting, hepatic and renal diseases, and various other serious illnesses. The company also directly supplies Captisol materials, a proprietary technology frequently integrated into many of its drug formulations. Established in 1987, Ligand Pharmaceuticals is headquartered in Emeryville, California.

Market cap$5.8B
Employees47
Ligand Pharmaceuticals Incorporated competitors & alternatives →
Netcapital Inc.NCPL · FintechBoston, United States
Public

Netcapital Inc. is a financial technology firm primarily known for its SEC-registered funding platform, Netcapital.com. This online portal facilitates capital raising for private enterprises while simultaneously providing a global investment avenue for individuals. Beyond its core platform, the company offers an extensive suite of support services. These encompass streamlined, automated onboarding, systematic handling of essential regulatory submissions, thorough compliance checks, and the creation of bespoke offering pages on its website. Netcapital.com also arranges for third-party transfer agency and custodial services. It actively promotes offerings through email marketing to its exclusive investor network and incorporates 'rolling closes,' allowing earlier liquidity access prior to an offering's official conclusion. Further assistance includes annual filing support and continuous operational guidance. Moreover, Netcapital Inc. extends its expertise through a range of advisory offerings. These services include fostering nascent technology startups, connecting companies with potential investors, and providing digital marketing solutions. They also cover website and software development, comprehensive message formulation (from pitch decks to advertising content), strategic business guidance, and specialized technology consulting. The firm additionally conducts various financial assessments and evaluations. Its offerings in this domain include business valuation reports, opinions on fairness and solvency, feasibility studies and valuations for Employee Stock Ownership Plans (ESOPs), assessments for non-cash charitable donations, economic analysis related to damages, intellectual property appraisals, and analyses of compensation structures. Established in 1984 and headquartered in Boston, Massachusetts, Netcapital Inc. operates as a subsidiary of NetCapital Systems LLC.

Market cap$12.5M
Employees21
Netcapital Inc. competitors & alternatives →
Northfield Bancorp, Inc.NFBK · BankingWoodbridge, United States
Public

Northfield Bancorp, Inc. acts as the holding company for Northfield Bank, providing a diverse array of financial services primarily to individual consumers and business clients. The institution offers a wide selection of deposit products, including certificates of deposit, traditional passbook and statement savings accounts, and money market accounts. Its transactional services feature negotiable order of withdrawal (NOW) accounts, alongside both interest-bearing and non-interest-bearing checking options. Furthermore, it manages individual retirement accounts (IRAs) and accepts brokered deposits. Beyond deposits, Northfield Bank extends various lending solutions. These encompass financing for multifamily and other commercial real estate properties, construction and land development projects, and general commercial and industrial loans. For residential customers, it provides one-to-four family home loans, in addition to home equity loans and lines of credit. The company strategically acquires various investment securities, such as mortgage-backed securities and corporate bonds, and places funds with other financial institutions. Its asset portfolio also comprises mortgage loans, additional mortgage-backed securities, and diverse other investments. As of December 31, 2021, Northfield Bancorp operated 38 full-service banking branches. These offices are located across Staten Island and Brooklyn, New York, as well as throughout Hunterdon, Middlesex, Mercer, and Union counties in New Jersey. Northfield Bancorp, Inc. was established in 1887 and maintains its corporate headquarters in Woodbridge, New Jersey.

Market cap$639.4M
Employees357
Northfield Bancorp, Inc. competitors & alternatives →
Ocular Therapeutix, Inc.OCUL · BiotechnologyBedford, United States
Public

Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a proprietary bioresorbable hydrogel technology to address a range of eye diseases and conditions. The company currently offers two key products: ReSure Sealant, an ophthalmic device designed to prevent fluid leakage from corneal incisions after cataract surgery, and DEXTENZA, a dexamethasone-based ophthalmic insert used to manage post-surgical inflammation and pain in the eye, as well as to treat allergic conjunctivitis. In addition to their commercial offerings, Ocular Therapeutix is actively developing several product candidates in various clinical stages, including: OTX-TKI, an axitinib intravitreal implant in Phase 1 clinical trials for wet age-related macular degeneration (AMD) and other retinal diseases. OTX-TIC, a travoprost intracameral implant, currently in Phase 2 studies for open-angle glaucoma and ocular hypertension. OTX-CSI, a cyclosporine intracanalicular insert that has successfully completed Phase 2 clinical trials for dry eye disease. OTX-DED, a dexamethasone intracanalicular insert undergoing Phase 2 evaluation for the temporary relief of dry eye symptoms. Strategic partnerships are also a significant part of Ocular Therapeutix's operations. This includes a collaboration with Regeneron Pharmaceuticals, Inc. focused on developing and commercializing products that combine Ocular Therapeutix's sustained-release hydrogel technology with Regeneron's large molecule VEGF-targeting compounds for retinal disease treatment. Another partnership with AffaMed Therapeutics Limited covers the development and commercialization of DEXTENZA and OTX-TIC. Additionally, a discovery-focused collaboration with Mosaic Biosciences aims to pinpoint novel targets and therapeutic agents for dry age-related macular degeneration (dAMD). Established in 2006, Ocular Therapeutix, Inc. maintains its headquarters in Bedford, Massachusetts.

Market cap$1.6B
Employees325
Ocular Therapeutix, Inc. competitors & alternatives →
Turning Point Brands, Inc.TPB · Consumer ProductsLouisville, United States
Public

Turning Point Brands, Inc., along with its affiliated companies, is engaged in the creation, promotion, and distribution of a diverse array of branded consumer products. Its operations are structured into three distinct divisions: Zig-Zag Products, Stoker's Products, and NewGen Products. The Zig-Zag Products division focuses on the marketing and distribution of rolling papers, cigarette tubes, pre-rolled cigars, 'make-your-own' cigar wraps, and related accessories, all sold under the well-known Zig-Zag brand. Conversely, the Stoker's Products division is responsible for manufacturing and commercializing moist snuff and loose-leaf chewing tobacco products. These are offered under several brand names including Stoker's, Beech-Nut, Durango, Trophy, and Wind River. The NewGen Products segment caters to individual consumers by marketing and distributing cannabidiol (CBD) isolate, liquid vapor items, and various other offerings free from tobacco and/or nicotine. This is achieved through its direct-to-consumer online platform, VaporFi, and its non-traditional retail outlet, VaporBeast. TPB's goods are supplied to a broad network of wholesale distributors and retail partners, encompassing independent and chain convenience stores, specialized tobacco shops, grocery stores, major retailers, and pharmacies. Originally established as North Atlantic Holding Company, Inc., the corporation adopted its current name, Turning Point Brands, Inc., in November 2015. Founded in 1988, Turning Point Brands, Inc. maintains its corporate headquarters in Louisville, Kentucky.

Market cap$1.5B
Employees310
Turning Point Brands, Inc. competitors & alternatives →
Alerus Financial CorporationALRS · BankingGrand Forks, United States
Public

Alerus Financial Corporation, operating primarily through its subsidiary Alerus Financial, National Association, delivers a broad spectrum of financial services to both commercial clients and individual consumers. The company organizes its operations across four distinct segments: Banking, Retirement and Benefit Services, Wealth Management, and Mortgage. Within its Banking segment, Alerus provides a comprehensive array of deposit solutions, including checking, savings, money market, and certificate of deposit accounts. It also supports businesses with robust treasury management products like electronic receivables management, remote deposit capture, cash vault services, and other cash management tools. Lending solutions encompass various commercial loans, such as business term loans, lines of credit, commercial real estate financing, and construction and land development loans, alongside consumer offerings like residential first and second mortgages and installment loans. The Retirement and Benefit Services division focuses on administering retirement plans, providing investment advisory services, managing employee stock ownership plans (ESOPs), and offering payroll, health savings accounts (HSAs), and other employee benefits, including individual retirement accounts (IRAs). Through Wealth Management, clients can access financial planning, investment management, personal and corporate trust services, estate administration, and custodial solutions. Additional offerings extend to debit and credit cards, modern online and mobile banking platforms, secure payment solutions, and exclusive private banking privileges, as well as flex spending accounts and government health insurance program services. Geographically, the company's banking services are delivered through fourteen offices located in North Dakota, Minnesota, and Arizona. Its Retirement and Benefit Services, however, boast a national footprint, serving clients in all 50 states from offices situated in Michigan, Minnesota, and Colorado. Founded in 1879, Alerus Financial Corporation was originally known as First National Bank North Dakota before adopting its current name in 2000. The company maintains its headquarters in Grand Forks, North Dakota.

Market cap$821.7M
Employees864
Alerus Financial Corporation competitors & alternatives →
Algorhythm Holdings, Inc.RIME · Media & EntertainmentFort Lauderdale, United States
Public

Algorhythm Holdings, Inc., along with its affiliated companies, operates globally in the consumer entertainment sector, specializing in karaoke. The company is responsible for designing, marketing, and distributing a range of audio equipment, accompanying accessories, and musical recordings. Its market presence spans North America, Australia, the United Kingdom, Europe, and other international territories. The company's diverse product lineup includes its flagship "Singing Machine" karaoke devices, licensed "Carpool Karaoke" microphone products, and the "Party Machine" brand for various microphones and portable Bluetooth options. They also offer "Singing Machine Kids" entertainment systems tailored for children and innovative connected vehicle karaoke devices. Beyond hardware, Algorhythm Holdings provides digital music services, including subscription access for iOS and Android platforms, a dedicated web download store, and integrated streaming capabilities for its devices. Their sales model primarily targets a broad spectrum of retailers, encompassing major national chains, warehouse clubs, department stores, lifestyle boutiques, specialty outlets, and direct-to-consumer channels via catalogs and showrooms. Originally incorporated in 1982 as The Singing Machine Company, Inc., the firm rebranded to Algorhythm Holdings, Inc. in September 2024. Its corporate headquarters are located in Fort Lauderdale, Florida.

Market cap$2.9M
Employees25
Algorhythm Holdings, Inc. competitors & alternatives →

Company intelligence, live

Profiles, competitors, funding, the investor graph, hiring signals, tech stacks, leadership and corporate events — for every company that matters, continuously updated.

Subscribe to Xcout Intel →